Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia

被引:1980
作者
Lina, G
Piémont, Y
Godail-Gamot, F
Bes, M
Peter, MO
Gauduchon, V
Vandenesch, F
Etienne, J
机构
[1] Fac Med, Ctr Natl Reference Toxemies Staphylococc, Bacteriol Lab, F-69372 Lyon 08, France
[2] Univ Strasbourg 1, Fac Med, Inst Bacteriol, Strasbourg, France
[3] Hop E Muller Moenschberg, Mulhouse, France
关键词
D O I
10.1086/313461
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Panton-Valentine leukocidin (PVL) is a cytotoxin that causes leukocyte destruction and tissue necrosis. It is produced by fewer than 5% of Staphylococcus aureus strains. A collection of 172 S. aureus strains were screened for PVL genes by polymerase chain reaction amplification. PVL genes were detected in 93% of strains associated with furunculosis and in 85% of those associated with severe necrotic hemorrhagic pneumonia (all community-acquired). They were detected in 55% of cellulitis strains, 50% of cutaneous abscess strains, 23% of osteomyelitis strains, and 13% of finger-pulp-infection strains. PVL genes were not detected in strains responsible for other infections, such as infective endocarditis, mediastinitis, hospital-acquired pneumonia, urinary tract infection, and enterocolitis, or in those associated with toxic-shock syndrome. It thus appears that PVL is mainly associated with necrotic lesions involving the skin or mucosa.
引用
收藏
页码:1128 / 1132
页数:5
相关论文
共 25 条
  • [11] Panton-Valentine leukocidin genes in a phage-like particle isolated from mitomycin C-treated Staphylococcus aureus V8 (ATCC 49775)
    Kaneko, J
    Kimura, T
    Kawakami, Y
    Tomita, T
    Kamio, Y
    [J]. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1997, 61 (11) : 1960 - 1962
  • [12] Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriophage φPVL carrying Panton-Valentine leukocidin genes
    Kaneko, J
    Kimura, T
    Narita, S
    Tomita, T
    Kamio, Y
    [J]. GENE, 1998, 215 (01) : 57 - 67
  • [13] EFFECTS OF STAPHYLOCOCCUS-AUREUS LEUKOCIDINS ON INFLAMMATORY MEDIATOR RELEASE FROM HUMAN GRANULOCYTES
    KONIG, B
    PREVOST, G
    PIEMONT, Y
    KONIG, W
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) : 607 - 613
  • [14] LEPPARD BJ, 1985, BRIT J DERMATOL, V112, P559, DOI 10.1111/j.1365-2133.1985.tb15264.x
  • [15] PATHOLOGICAL CASE-OF-THE-MONTH - FATAL HEMORRHAGIC STAPHYLOCOCCAL PNEUMONIA
    OLCAY, L
    SECMEER, G
    GOGUS, S
    AKCOREN, Z
    [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1995, 149 (08): : 925 - 926
  • [16] PETERSDORF RG, 1974, HARRISONS PRINCIPLES, P754
  • [17] Severe community acquired pneumonia due to Staphylococcus aureus
    Petros, S
    Eggers, B
    Heuer, M
    Plath, A
    Kosling, S
    Engelmann, L
    Schauer, HJ
    [J]. INTENSIVE CARE MEDICINE, 1998, 24 (02) : 189 - 189
  • [18] PATIENT SELECTION FOR CLINICAL INVESTIGATION OF VENTILATOR-ASSOCIATED PNEUMONIA - CRITERIA FOR EVALUATING DIAGNOSTIC-TECHNIQUES
    PINGLETON, SK
    FAGON, JY
    LEEPER, KV
    [J]. CHEST, 1992, 102 (05) : S553 - S556
  • [19] EPIDEMIOLOGIC DATA ON STAPHYLOCOCCUS-AUREUS STRAINS PRODUCING SYNERGOHYMENOTROPIC TOXINS
    PREVOST, G
    COUPPIE, P
    PREVOST, P
    GAYET, S
    PETIAU, P
    CRIBIER, B
    MONTEIL, H
    PIEMONT, Y
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1995, 42 (04) : 237 - 245
  • [20] PREVOST G, 1995, INFECT IMMUN, V63, P4121